ストックスクリーナーアプリを入手
38.54
0.05%
-0.02
アフターアワーズ：
38.50
-0.04
-0.10%
前日終値:
$38.56
開ける：
$38.72
24時間の取引高:
5.95M
Relative Volume:
1.49
時価総額：
$16.66B
収益：
$2.31B
当期純損益:
$1.66B
株価収益率:
16.78
EPS:
2.297
ネットキャッシュフロー:
$827.02M
1週間 パフォーマンス:
+3.32%
1か月 パフォーマンス:
+7.03%
6か月 パフォーマンス:
+16.26%
1年 パフォーマンス:
+47.04%
1日の値動き範囲:
$38.51
$39.40
1週間の範囲:
$36.03
$41.24
52週間の値動き範囲:
$24.05
$41.24
Royalty Pharma Plc Stock (RPRX) Company Profile
名前
Royalty Pharma Plc
セクター
電話
(212) 883-0200
住所
110 EAST 59TH STREET, NEW YORK, NY
RPRX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
38.54 | 16.47B | 2.31B | 1.66B | 827.02M | 2.297 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.20 | 103.89B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
654.74 | 69.11B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
441.70 | 58.49B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
869.83 | 52.62B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
191.92 | 40.46B | 447.02M | -1.18B | -906.14M | -6.1812 |
Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-30 | 開始されました | Goldman | Buy |
| 2025-05-16 | 開始されました | Morgan Stanley | Overweight |
| 2024-06-03 | ダウングレード | UBS | Buy → Neutral |
| 2022-06-14 | 再開されました | UBS | Buy |
| 2022-05-13 | 開始されました | Scotiabank | Sector Outperform |
| 2022-04-27 | 開始されました | Goldman | Buy |
| 2022-04-14 | アップグレード | JP Morgan | Neutral → Overweight |
| 2022-04-06 | 再開されました | Morgan Stanley | Overweight |
| 2021-10-29 | アップグレード | Citigroup | Neutral → Buy |
| 2021-07-30 | 開始されました | Tigress Financial | Buy |
| 2020-11-09 | アップグレード | UBS | Neutral → Buy |
| 2020-07-14 | 開始されました | Evercore ISI | In-line |
| 2020-07-13 | 開始されました | BofA Securities | Buy |
| 2020-07-13 | 開始されました | Citigroup | Neutral |
| 2020-07-13 | 開始されました | Cowen | Outperform |
| 2020-07-13 | 開始されました | Goldman | Neutral |
| 2020-07-13 | 開始されました | JP Morgan | Neutral |
| 2020-07-13 | 開始されました | Morgan Stanley | Equal-Weight |
| 2020-07-13 | 開始されました | SunTrust | Buy |
| 2020-07-13 | 開始されました | UBS | Neutral |
すべてを表示
Royalty Pharma Plc (RPRX) 最新ニュース
Why analysts remain bullish on Royalty Pharma plc stockRate Hike & Weekly Setup with ROI Potential - newser.com
Top chart patterns to watch in Royalty Pharma plc2025 Valuation Update & Accurate Entry and Exit Point Alerts - newser.com
Can Royalty Pharma plc stock rebound after recent weaknessJuly 2025 Patterns & Community Supported Trade Ideas - newser.com
Royalty Pharma PLC $RPRX Shares Sold by Los Angeles Capital Management LLC - MarketBeat
Metis Global Partners LLC Acquires 30,959 Shares of Royalty Pharma PLC $RPRX - MarketBeat
How Royalty Pharma plc (RPD) stock performs in easing cycles2025 Price Momentum & Community Driven Trade Alerts - newser.com
AGF Management Ltd. Has $3.36 Million Stock Position in Royalty Pharma PLC $RPRX - MarketBeat
Published on: 2025-11-10 02:13:10 - newser.com
Historical volatility pattern of Royalty Pharma plc visualizedMarket Volume Summary & Consistent Return Investment Signals - newser.com
Will Royalty Pharma plc (RPD) stock maintain strong growthQuarterly Earnings Summary & Precise Buy Zone Identification - newser.com
Why Royalty Pharma plc (RPD) stock could outperform next yearVolume Spike & Real-Time Price Movement Reports - newser.com
Using Python tools to backtest Royalty Pharma plc strategies2025 Top Decliners & Long-Term Safe Investment Plans - newser.com
Applying chart zones and confluence areas to Royalty Pharma plc2025 Winners & Losers & Real-Time Buy Signal Alerts - newser.com
Quantitative breakdown of Royalty Pharma plc recent moveJuly 2025 Pullbacks & Stock Timing and Entry Methods - newser.com
Is Royalty Pharma plc (RPD) stock attractive post correctionChart Signals & Daily Momentum Trading Reports - newser.com
Analyzing net buyer seller activity in Royalty Pharma plcTrade Ideas & Intraday High Probability Setup Alerts - newser.com
Why retail investors pile into Royalty Pharma plc stock2025 Investor Takeaways & Daily Technical Stock Forecast Reports - newser.com
(RPRX) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
Will Royalty Pharma plc (RPD) stock hit Wall Street targetsQuarterly Trade Review & Growth Focused Entry Reports - newser.com
Achmea Investment Management B.V. Invests $1.23 Million in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma (NASDAQ:RPRX) Announces Quarterly Earnings Results, Beats Expectations By $0.06 EPS - MarketBeat
Published on: 2025-11-07 09:50:08 - newser.com
Royalty Pharma Plc Hits New 52-Week High of $38.09 - Markets Mojo
C WorldWide Group Holding A S Has $22.60 Million Stock Position in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma PLC $RPRX Position Increased by Bryn Mawr Trust Advisors LLC - MarketBeat
Royalty Pharma raises 2025 top line guidance to $3.2B–$3.25B amid strong portfolio expansion - MSN
Is Royalty Pharma plc stock a safe investment in uncertain marketsWeekly Profit Report & AI Forecast Swing Trade Picks - newser.com
Is Royalty Pharma plc reversing from oversold territoryPortfolio Performance Summary & Consistent Growth Equity Picks - newser.com
Goldman Sachs raises Royalty Pharma stock price target to $45 on strong results By Investing.com - Investing.com South Africa
Goldman Sachs raises Royalty Pharma stock price target to $45 on strong results - Investing.com Australia
Royalty pharma to buy its external manager, announces $3B share buyback - MSN
What’s the recovery path for long term holders of Royalty Pharma plc2025 Performance Recap & Step-by-Step Swing Trade Plans - newser.com
Published on: 2025-11-06 05:49:05 - newser.com
Royalty Pharma (RPRX) PT Raised to $45 at Goldman Sachs - StreetInsider
Royalty Pharma Reports Strong Q3 2025 Results - TipRanks
Royalty Pharma Q3 2025 slides: Portfolio receipts up 11%, guidance raised - Investing.com Nigeria
Why Royalty Pharma plc (RPD) stock could rally stronglyJuly 2025 Breakouts & Reliable Volume Spike Alerts - newser.com
Royalty Pharma (RPRX) Beats Q3 Earnings and Revenue Estimates - sharewise.com
Royalty Pharma (RPRX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - sharewise.com
Royalty Pharma’s Q3 2025 Earnings Call Highlights - TipRanks
Royalty Pharma (RPRX) Earnings Soar 52% as Margin Surge Challenges Bearish Narratives - Yahoo Finance
Does Royalty Pharma plc qualify in momentum factor screeningMarket Performance Report & Daily Risk Controlled Trade Plans - newser.com
Is Royalty Pharma plc stock supported by strong fundamentalsJuly 2025 Macro Moves & Scalable Portfolio Growth Methods - fcp.pa.gov.br
Can Royalty Pharma plc stock beat analyst upgradesGlobal Markets & Long-Term Safe Investment Plans - newser.com
Royalty Pharma's Strong Portfolio Growth and Manager Acquisition Boost Long-Term Outlook - Morningstar
Is Royalty Pharma plc (RPD) stock undervalued historicallyJuly 2025 Opening Moves & Target Return Focused Stock Picks - Fundação Cultural do Pará
Royalty Pharma Plc (RPRX) 財務データ
収益
当期純利益
現金流量
EPS
1.40%
大文字化:
|
ボリューム (24 時間):